Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- 80 and over (1)
- Adolescent (1)
- Adult (1)
- Aged (1)
- Anti-asthmatic agents/therapeutic use (1)
-
- Antibodies (1)
- Asthma/drug therapy/epidemiology/complications (1)
- Cervicovaginal lavage (CVL)2 (1)
- Child (1)
- Chronic disease (1)
- Comorbidity (1)
- Double-blind method (1)
- Drug-induced (1)
- Female (1)
- Humanized/therapeutic use (1)
- Humans (1)
- Iron3 (1)
- Lichen planus (1)
- Male (1)
- Manganese4 (1)
- Middle Aged (1)
- Monoclonal (1)
- Nasal polyps/drug therapy/epidemiology/complications (1)
- Ocrelizumab (1)
- Patient reported outcome measures (1)
- Quality of life (1)
- Rhinitis/drug therapy/epidemiology/complications (1)
- Rhinosinusitis (1)
- Sinusitis/drug therapy/epidemiology/complications (1)
- Trace metal homeostasis5 (1)
Articles 1 - 3 of 3
Full-Text Articles in Biological Factors
Tezepelumab's Effects On Patient-Reported Symptoms In Severe Asthma, Overall And With History Of Comorbid Chronic Rhinosinusitis With Nasal Polyps (Crswnp), Njira L. Lugogo, Joseph K. Han, Anju T. Peters, Stella E. Lee, Monica Kraft, Mary Kay Margolis, Sonia F. Shenoy, Nicole Martin, Shradha Chandarana, Christopher S. Ambrose
Tezepelumab's Effects On Patient-Reported Symptoms In Severe Asthma, Overall And With History Of Comorbid Chronic Rhinosinusitis With Nasal Polyps (Crswnp), Njira L. Lugogo, Joseph K. Han, Anju T. Peters, Stella E. Lee, Monica Kraft, Mary Kay Margolis, Sonia F. Shenoy, Nicole Martin, Shradha Chandarana, Christopher S. Ambrose
Department of Otolaryngology (ENT) Faculty Publications
Background
Tezepelumab (an anti-thymic stromal lymphopoietin monoclonal antibody) treatment resulted in reduced exacerbations and improved sino-nasal symptoms and health-related quality of life in patients with severe uncontrolled asthma (SUA) and chronic rhinosinusitis with nasal polyps (CRSwNP) in the NAVIGATOR study.
Objective
To evaluate the effect of tezepelumab versus placebo on sleep disturbances, activity levels, and physical exertion tolerance in NAVIGATOR patients with SUA overall and in those with past medical history of comorbid CRSwNP.
Methods
Patients (12-80 years old) with SUA were randomized to receive tezepelumab 210 mg or placebo subcutaneously every 4 weeks for 52 weeks. Patient responses to …
Drug-Induced Lichen Planus Associated With Ocrelizumab, Avery Seward, John D. Strickley, Jeffrey P. Callen
Drug-Induced Lichen Planus Associated With Ocrelizumab, Avery Seward, John D. Strickley, Jeffrey P. Callen
Department of Medicine Faculty Publications
This case report highlights recurrent cutaneous lichen planus as a rare adverse effect of ocrelizumab, with flares occurring after each infusion and improving with prophylactic prednisone. Recognizing this association may help clinicians diagnose and manage similar cases while allowing patients to continue an otherwise effective therapy.
Cervicovaginal Lavage Fluid Iron And Manganese Levels In Women With And Without Vaginitis, Barbara Kozma, David Ratonyi, Bence Kozma, Peter Takacs, Attila G. Sipos
Cervicovaginal Lavage Fluid Iron And Manganese Levels In Women With And Without Vaginitis, Barbara Kozma, David Ratonyi, Bence Kozma, Peter Takacs, Attila G. Sipos
Department of Obstetrics & Gynecology Faculty Publications
Transition metals such as iron and manganese are critical for cellular metabolism, redox balance, and immune function, and they also influence host–pathogen interactions. Vaginitis is characterized by mucosal inflammation that may alter local trace-element homeostasis. We hypothesize that inflammatory conditions such as vaginitis may be associated with altered cervicovaginal iron and manganese levels. We performed a prospective, single-center cohort study at the University of Debrecen (Hungary) between April 2023 and April 2024, enrolling 80 women ≥ 18 years with vulvovaginal complaints. Participants were assessed at baseline and at weeks 4, 8, and 12 with clinical evaluation and cervicovaginal lavage (CVL) …